Reasons for discontinuation of subcutaneous interferon β-1a three times a week among patients with multiple sclerosis: a real-world cohort study
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s12883-017-0831-4
Published Online: 2017-03-23
Published Print: 2017-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Sabidó-Espin, Meritxell
Munschauer, Rick